博济医药：9月12日召开董事会会议

Core Viewpoint - Boji Pharmaceutical announced a board meeting to discuss the use of idle funds for cash management, indicating a strategic move to optimize financial resources [1] Company Summary - Boji Pharmaceutical's revenue composition for the first half of 2025 shows that the service industry accounts for 99.46% of total revenue, while other businesses contribute 0.54% [1] - As of the report, Boji Pharmaceutical has a market capitalization of 4.2 billion yuan [1] Industry Context - The announcement of cash management strategies reflects broader trends in the pharmaceutical industry, where companies are increasingly focusing on financial efficiency and resource allocation [1]